EUVIMEDEUVIMED entdecken
Crossref

Association between body composition phenotypes and treatment toxicity in women with cervical cancer undergoing chemoradiotherapy

Mariah Azevedo Aredes, Nathália Silva de Paula, Gabriela Villaça Chaves

Nutrition · 2024

DOI: 10.1016/j.nut.2024.112539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, 2024. Verfasst von Mariah Azevedo Aredes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition and Cancer Research Group, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Body Composition, Chemoradiotherapy, Phenotype. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: FAPERJ.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To identify whether there is an association between body composition phenotypes and toxicity to chemoradiotherapy in women with cervical cancer. METHODS: This is a prospective cohort study that included 330 adult patients with cervical cancer treated with chemoradiotherapy. Computed tomography images were used to assess skeletal muscle index (SMI) and radiodensity (SMD), total adipose tissue index, and visceral adipose tissue index. Chemoradiotherapy toxicity was assessed weekly, and toxicity-induced modification of treatment (TIMT) was considered as any severe adverse event resulting in treatment interruption, delay, or dose reduction. RESULTS: Approximately 45% of the patients presented at least one unfavorable body composition parameter (lower SMI, lower SMD, higher total adipose tissue index, or higher visceral adipose tissue index), 23% had two conditions, and 3% had three conditions. The incidence of toxicity ≥ grade 3 and TIMT was 55% and 30%, respectively. For adverse events ≥ grade 3, lower SMI was the determining factor for worse outcomes when evaluated alone or combined with lower SMD and normal adiposity. All body composition phenotypes were associated with TIMT, increasing the risk when both conditions were present. CONCLUSIONS: Lower SMI was an independent factor for the higher number of adverse events, as it remained a risk factor when analyzed in isolation or in association with adipose tissue. Women with excess adipose tissue associated with lower muscle mass had a risk approximately 4 times higher of delaying or interrupting chemoradiotherapy. Furthermore, for the sum of unfavorable conditions, there was a progressive increase in the risk of TIMT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsBody CompositionChemoradiotherapyPhenotypeHumansFemaleMiddle AgedProspective StudiesAdultIntra-Abdominal FatAgedMuscle, SkeletalTomography, X-Ray ComputedRisk Factors

Stichwörter der Autor:innen

AdiposityChemotherapyComputer tomographyGynecological tumorsMuscle radiodensitySkeletal muscle

Autor:innen und Institutionen

  • Nutrition and Cancer Research Group, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil.
  • Nutrition and Cancer Research Group, Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil.
  • Nutrition Department, Nutrition and Cancer Research Group, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil. Electronic address: gchaves@inca.gov.br.

Förderung

  • FAPERJ

Zitieren

APA

Aredes, M. A., de Paula, N. S., & Villaça Chaves, G. (2024). Association between body composition phenotypes and treatment toxicity in women with cervical cancer undergoing chemoradiotherapy. Nutrition. https://doi.org/10.1016/j.nut.2024.112539

Vancouver

Aredes MA, de Paula NS, Villaça Chaves G. Association between body composition phenotypes and treatment toxicity in women with cervical cancer undergoing chemoradiotherapy. Nutrition. 2024. doi:10.1016/j.nut.2024.112539

BibTeX
@article{Aredes2024,
  author = {Aredes, Mariah Azevedo and de Paula, Nathália Silva and Villaça Chaves, Gabriela},
  title = {Association between body composition phenotypes and treatment toxicity in women with cervical cancer undergoing chemoradiotherapy},
  journal = {Nutrition},
  year = {2024},
  doi = {10.1016/j.nut.2024.112539}
}
Kostenlos starten →